Search results
Results from the WOW.Com Content Network
Phage therapy, viral phage therapy, or phagotherapy is the therapeutic use of bacteriophages for the treatment of pathogenic bacterial infections. [1] [2] [3] This therapeutic approach emerged at the beginning of the 20th century but was progressively replaced by the use of antibiotics in most parts of the world after the Second World War.
He was co-discoverer of bacteriophages (viruses that infect bacteria) and experimented with the possibility of phage therapy. [2] D'Hérelle has also been credited for his contributions to the larger concept of applied microbiology. [3] d'Hérelle was a self-taught microbiologist.
Structural model at atomic resolution of bacteriophage T4 [1] The structure of a typical myovirus bacteriophage Anatomy and infection cycle of bacteriophage T4.. A bacteriophage (/ b æ k ˈ t ɪər i oʊ f eɪ dʒ /), also known informally as a phage (/ ˈ f eɪ dʒ /), is a virus that infects and replicates within bacteria and archaea.
Monoclonal antibody therapy – targeted treatment using engineered antibodies produced by identical immune cells to fight pathogens. Inoculation – introduction of a pathogen or antigen into the body to stimulate immunity. Phage therapy – treatment using bacteriophage viruses that infect and kill bacteria to combat bacterial infections.
The 'Nuts and Bolts' of Phage Therapy. a special issue of the journal, Current Pharmaceutical Biotechnology, consisting of six articles on phage therapy, plus an editorial. Carnazza, S., Guglielmino, S. eds. 2010. Phage Display As a Tool for Synthetic Biology. Nova Science Publishers, Hauppauge, New York. ISBN 978-1-60876-987-2, Google Books
Phage therapy—viruses that specifically target pathogenic bacteria—has been developed over the last 80 years, primarily in the former Soviet Union, where it was used to prevent diarrhea caused by E. coli. [55] Presently, phage therapy for humans is available only at the Phage Therapy Center in the Republic of Georgia and in Poland. [56]
The George Eliava Institute of Bacteriophage, Microbiology and Virology [1] (aka Tbilisi Institute) has been active since the 1930s in the field of phage therapy, which is used to combat microbial infection (cf. antibiotic-resistant strains).
The phi X 174 (or ΦX174) bacteriophage is a single-stranded DNA virus that infects Escherichia coli. This virus was isolated in 1935 by Nicolas Bulgakov [1] in Félix d'Hérelle's laboratory at the Pasteur Institute, from samples collected in Paris sewers. Its characterization and the study of its replication mechanism were carried out from ...